Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.06% Nasdaq Down 0.58%
Streaming
Ticker Tape: On

Zalicus Inc. (ZLCS)

-NasdaqCM
1.18 Down 0.03(2.48%) 1:06PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:1.21
Open:1.21
Bid:1.17 x 1100
Ask:1.18 x 500
1y Target Est:1.20
Beta:2.05
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.16 - 1.21
52wk Range:0.88 - 8.28
Volume:130,346
Avg Vol (3m):768,387
Market Cap:30.70M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZLCSDown 2.48%30.70M
ACTDown 0.70%35.58B
NVSDown 0.16%209.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.16
Quarterly EPS Est (Mar-14) :0.20
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback